Sort
27,075 grants matching “cholesterol”
IDENTIFICATION OF NOVEL CANDIDATE GENES FOR CVD
$552,070John Blangero · Texas Biomedical Research Institute · P01 · FY2010 · HL
IDENTIFICATION OF NOVEL CANDIDATE GENES FOR CVD
$552,066John Blangero · Texas Biomedical Research Institute · P01 · FY2012 · HL
Northern Manhattan diabetes community health
$552,064Olveen Carrasquilo · Columbia University Health Sciences · P60 · FY2012 · MD
Moving Forward: A weight loss program for African-American breast cancer survivo
$552,052Melinda R Stolley · University Of Illinois At Chicago · R01 · FY2011 · CA
Risk Factors for CVD in Women
$551,976Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2015 · HL
Bile acids and insulin sensitivity
$551,959Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2019 · DK
RECK regulation of NASH and fibrosis
$551,909Randy Scott Rector · University Of Missouri-Columbia · R01 · FY2025 · DK
RECK regulation of NASH and fibrosis
$551,909Randy Scott Rector · University Of Missouri-Columbia · R01 · FY2023 · DK
RECK regulation of NASH and fibrosis
$551,909Randy Scott Rector · University Of Missouri-Columbia · R01 · FY2022 · DK
Bioactive lipid mediators and reactive oxygen species
$551,873Robert Carl Murphy · National Jewish Health · P01 · FY2007 · HL
Neurodevelopmental and neurodegenerative effects of environmental determinants: altering neural cellular populations impacting homeostatic functions and inflammatory response.
$551,850Nicholas Francis Fitz · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG
Neurodevelopmental and neurodegenerative effects of environmental determinants: altering neural cellular populations impacting homeostatic functions and inflammatory response.
$551,850Nicholas Francis Fitz · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG
Genetic Epidemiology of Change in CVD Risk Factors
$551,842David Michael Hallman · University Of Texas Hlth Sci Ctr Houston · R01 · FY2009 · HL
CTRP and Metabolic Control
$551,838Guang William Wong · Johns Hopkins University · R01 · FY2022 · DK
CTRP and Metabolic Control
$551,838Guang William Wong · Johns Hopkins University · R01 · FY2020 · DK
CTRP and Metabolic Control
$551,838Guang William Wong · Johns Hopkins University · R01 · FY2023 · DK
CTRP and Metabolic Control
$551,838Guang William Wong · Johns Hopkins University · R01 · FY2021 · DK
Depot formulation of a D-peptide HIV entry inhibitor
$551,835Alan L Mueller · Navigen, Inc. · R01 · FY2019 · AI
AAV-mediated gene therapy for CNS disease correction in feline NPC1 disease
$551,828Charles H Vite · University Of Pennsylvania · R01 · FY2022 · NS
AAV-mediated gene therapy for CNS disease correction in feline NPC1 disease
$551,828Charles H Vite · University Of Pennsylvania · R01 · FY2023 · NS
Case Management for Underserved Hispanic Type 2 Diabetes Populations
$551,816Garry W Welch · Baystate Medical Center, Inc. · R01 · FY2012 · DK
Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors
$551,762Michael Karin · University Of California, San Diego · R01 · FY2020 · CA
Imaging Immunoreceptor Domain Dynamics
$551,689Erin D Sheets · University Of Minnesota Duluth · · FY2009 · BIO
Cellular Cholesterol and Podocyte function in Diabetic Kidney Disease
$551,375Alessia Fornoni · University Of Miami School Of Medicine · R01 · FY2016 · DK
Genetic Approaches to Cholesterol Metabolism in Humans
$551,264Helen H. Hobbs · Ut Southwestern Medical Center · P01 · FY2011 · HL